Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker AUPH
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 30, 2026 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 19, 2026 | AUPH Aurinia Pharmaceuticals Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 6, 2026 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 4, 2026 | AUPH Aurinia Pharmaceuticals Inc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 11, 2026 | AUPH Aurinia Pharmaceuticals Inc | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| May 7, 2026 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 3, 2026 | AUPH Aurinia Pharmaceuticals Inc | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 3, 2026 | AUPH Aurinia Pharmaceuticals Inc | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 23, 2026 | AUPH Aurinia Pharmaceuticals Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 26, 2026 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 4, 2025 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 31, 2025 | AUPH Aurinia Pharmaceuticals Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 31, 2025 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 30, 2025 | AUPH Aurinia Pharmaceuticals Inc | 8.01 Other Events | 8-K | 8-K ↗ |
| May 15, 2025 | AUPH Aurinia Pharmaceuticals Inc | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 15, 2025 | AUPH Aurinia Pharmaceuticals Inc | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 15, 2025 | AUPH Aurinia Pharmaceuticals Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 12, 2025 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 27, 2025 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 7, 2024 | AUPH Aurinia Pharmaceuticals Inc | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 7, 2024 | AUPH Aurinia Pharmaceuticals Inc | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Nov 7, 2024 | AUPH Aurinia Pharmaceuticals Inc | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances